Latest Health News
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
Lead investor confirmed his intention to maintain his current shareholdings.Company does not…
Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Cosentyx is the only IL-17A inhibitor approved for this population, and the…
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026 21:03 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026 20:30 ET | Source: Indivior Pharmaceuticals Inc. RICHMOND, Va.,…
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the…
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
March 11, 2026 19:21 ET | Source: Mesoblast Limited NEW YORK, March…
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services…
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
-- Issues Statement in Response to DOMA’s Nomination of Director Candidates --…
Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher BioFollows breakthrough non-human…
